Tag: Hatch-Waxman Act
Generic drugs don't appear immediately after patent expiration. Legal barriers, patent thickets, and regulatory delays often push availability out by 18 months or more - costing patients billions.
Authorized generics let brand drug companies launch their own generic versions, undercutting independent competitors and reducing true market competition. Here’s how they distort the system meant to lower drug prices.
